Neurocrine Biosciences Completes Acquisition of Soleno Therapeutics - PR Newswire
HealthcareMerger
Neurocrine Biosciences→Soleno Therapeutics
May 18, 2026
Neurocrine Biosciences — Acquisitions & M&A Deals
5 dealsTracking 5 M&A deals by Neurocrine Biosciences.
T/A - SOLENO THERAPEUTICS INC (0001484565) (Subject) — SEC SC TO Filing
HealthcareCaliforniaMerger
Neurocrine Biosciences→Soleno Therapeutics
Apr 28, 2026
T/A - NEUROCRINE BIOSCIENCES INC (0000914475) (Filed by) — SEC SC TO Filing
HealthcareCaliforniaMerger
Neurocrine Biosciences→Soleno Therapeutics
Apr 28, 2026
T - SOLENO THERAPEUTICS INC (0001484565) (Subject) — SEC SC TO Filing
HealthcareCaliforniaMerger
Neurocrine Biosciences→Soleno Therapeutics
Apr 20, 2026
C - SOLENO THERAPEUTICS INC (0001484565) (Subject) — SEC SC TO Filing
HealthcareCaliforniaMerger
Neurocrine Biosciences→Soleno Therapeutics
Apr 6, 2026